Grants & Grantees
Established in 1996, the Doris Duke Charitable Foundation (DDCF) supports four national grant-making programs: the Arts Program, the Child Abuse Prevention Program, the Environment Program and the Medical Research Program. It also supports the African Health Initiative as well as the Doris Duke Foundation for Islamic Art, which has one grant-making program: the Building Bridges Program. All the before-mentioned programs and initiatives are headquartered in DDCF’s New York office.
In order to develop the foundation’s grant-making strategies, the foundation's program staff conducts extensive research to identify gaps or needs in the fields it supports. Typically, this research leads to the development of a grant "initiative," which supports a set of related grants that advance a specific goal or objective. Once an initiative is developed, grants are awarded in a variety of ways, including foundation-initiated invitations to apply, re-granting competitions that are administered by service organizations and competitions that are run using request-for-proposal processes. Occasionally, the foundation also supports opportunistic grants that are more broadly related to the programs' missions.
DDCF’s activities are also guided by the will and individual passions of Doris Duke, who endowed the foundation with her personal assets.
While each program takes a different approach to the way it administers grants, all require that potential grantees be publicly supported 501(c)(3) tax-exempt organizations based in the United States. Click below to read more about each program’s approach to making grants to organizations.
Individuals may apply for grants through some of DDCF’s re-granting programs administered by intermediary organizations. Not all DDCF programs offer such opportunities. Click below to learn more about each program’s approach.
Open Competitions &
What We're Learning
Elizabeth Myers, Ph.D., program director for Medical Research, shares why DDCF joined 22 other organizations in supporting a committee convened by the Institute of Medicine (IOM) to develop guiding principles for the responsible sharing of clinical trial data--and what came out of that work.